Core One Labs Inc. (CLABF)
Core One Labs Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $471. On trailing twelve-month figures it carries a trailing P/E of -0.28, a net margin of -3485.4%. Its beta of 0.53 implies it has historically moved less than the broad market.
Core One Labs Inc. functions as a biotechnology research and life sciences firm. Its primary objective involves bringing psychedelic medications to the market, employing several key strategies. These include developing innovative delivery methods, offering psychedelic-assisted psychotherapy, and manufacturing API-grade psilocybin. The company also developed CannaStrips technology, which facilitates the bioavailability of cannabis compounds through infused strips. Complementing its core activities, Core One Labs provides a range of additional services such as consulting, financing, and micro cultivation support. It further operates medical and wellness clinics, supplies natural health products, and offers news dissemination services. Established in 2010, the company, formerly known as Lifestyle Delivery Systems Inc., adopted its current name in September 2019 and is headquartered in Vancouver, Canada.
Core One Labs Inc. is most often compared with the following Healthcare names: